Active Ingredient History
Glutathione is an antioxidant in plants, animals, fungi, and some bacteria and archaea. Glutathione is capable of preventing damage to important cellular components caused by reactive oxygen species such as free radicals, peroxides, lipid peroxides, and heavy metals. It is a tripeptide with a gamma peptide linkage between the carboxyl group of the glutamate side chain and cysteine. The carboxyl group of the cysteine residue is attached by normal peptide linkage to glycine. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Biliary Tract Diseases (Phase 3)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Cardiovascular Diseases (Phase 3)
COVID-19 (Phase 2)
Cystic Fibrosis (Phase 3)
Dermatology (Phase 1)
End Stage Liver Disease (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Glutathione (Phase 1)
Hamartoma (Phase 3)
HIV Infections (Phase 2)
Leukemia (Phase 2)
Liver Failure (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Neurotoxicity Syndromes (Phase 3)
Ovarian Neoplasms (Phase 3)
Pain (Phase 3)
Pancreatic Neoplasms (Phase 2)
Parkinson Disease (Phase 2)
Peripheral Nerve Injuries (Phase 3)
Persian Gulf Syndrome (Phase 1/Phase 2)
Reperfusion Injury (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue